These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11130325)

  • 21. Alzheimer's disease: the pharmacological pathway.
    Allain H; Bentué-Ferrer D; Tribut O; Gauthier S; Michel BF; Drieu-La Rochelle C
    Fundam Clin Pharmacol; 2003 Aug; 17(4):419-28. PubMed ID: 12914543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current and future treatments for cognitive deficits in dementia.
    McLendon BM; Chen GG; Doraiswamy PM
    Curr Psychiatry Rep; 2000 Feb; 2(1):20-3. PubMed ID: 11122927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing!
    Tabet N
    Age Ageing; 2006 Jul; 35(4):336-8. PubMed ID: 16788077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the treatment of Alzheimer's disease.
    Sloane PD
    Am Fam Physician; 1998 Nov; 58(7):1577-86, 1589-90. PubMed ID: 9824956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic options in Alzheimer's disease.
    Moreira PI; Zhu X; Nunomura A; Smith MA; Perry G
    Expert Rev Neurother; 2006 Jun; 6(6):897-910. PubMed ID: 16784412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapies for Alzheimer's disease.
    Melnikova I
    Nat Rev Drug Discov; 2007 May; 6(5):341-2. PubMed ID: 17539055
    [No Abstract]   [Full Text] [Related]  

  • 27. [Alzheimer's disease: from brain lesions to new drugs].
    Forette F; Hauw JJ
    Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
    Parnetti L; Senin U; Mecocci P
    Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donepezil for severe Alzheimer's disease.
    Kida Y; Sato T
    Lancet; 2006 Jul; 368(9533):361; author reply 362. PubMed ID: 16876653
    [No Abstract]   [Full Text] [Related]  

  • 30. Alzheimer disease therapeutics.
    Irizarry MC; Hyman BT
    J Neuropathol Exp Neurol; 2001 Oct; 60(10):923-8. PubMed ID: 11589422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease: new horizons in diagnosis and treatment.
    Rankin L
    Iowa Med; 1997; 87(5):199-201. PubMed ID: 9149495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving the diagnosis and treatment of Alzheimer's disease.
    Salloway S
    Med Health R I; 2006 May; 89(5):166-8. PubMed ID: 16764297
    [No Abstract]   [Full Text] [Related]  

  • 33. Combination drug therapy for Alzheimer's disease: what is evidence-based, and what is not?
    Xiong G; Doraiswamy PM
    Geriatrics; 2005 Jun; 60(6):22-6. PubMed ID: 15948662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-cholinergic strategies for treating and preventing Alzheimer's disease.
    Doraiswamy PM
    CNS Drugs; 2002; 16(12):811-24. PubMed ID: 12421115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current approaches in the treatment of Alzheimer's disease.
    Shah RS; Lee HG; Xiongwei Z; Perry G; Smith MA; Castellani RJ
    Biomed Pharmacother; 2008; 62(4):199-207. PubMed ID: 18407457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anticholinesterase agents in Alzheimer's disease].
    Ventura M; Sternon J
    Rev Med Brux; 2001 Sep; 22(4):A387-93. PubMed ID: 11680206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The treatment of Alzheimer's disease].
    Ankri J
    Rev Neurol (Paris); 2003 Sep; 159(8-9):819-24. PubMed ID: 13679729
    [No Abstract]   [Full Text] [Related]  

  • 38. What's hot, what's not, in dementia drugs. Part II.
    Buckwalter KC
    J Gerontol Nurs; 1997 Dec; 23(12):46-7. PubMed ID: 9460415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council.
    Fillit H; Cummings J
    Manag Care Interface; 2000 Jan; 13(1):51-6. PubMed ID: 10747691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New therapeutic approaches to Alzheimer's disease].
    de Ladoucette O
    Soins Gerontol; 2006; (61):11-3. PubMed ID: 17063846
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.